Title : Antibody-nanoparticle conjugate constructed with trastuzumab and nanoparticle albumin-bound paclitaxel for targeted therapy of human epidermal growth factor receptor 2-positive gastric cancer.

Pub. Date : 2018 Mar

PMID : 29328489

1 Functional Relationships(s)
Compound Name
Protein Name
1 In conclusion, trastuzumab/nab-paclitaxel could mediate targeted therapy and enhance antitumor efficacy, which could represent a novel therapeutic agent for HER2-positive GC. nab erb-b2 receptor tyrosine kinase 2 Homo sapiens